Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,466 GBX | +0.73% | +0.50% | +17.60% |
Jun. 12 | AstraZeneca's Farxiga Approved For Treating Pediatric Type-2 Diabetes in U.S. | DJ |
Jun. 12 | AstraZeneca Gets FDA Approval for Pediatric Type-2 Diabetes Control Drug | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.60% | 244B | |
+48.79% | 780B | |
+41.76% | 627B | |
+19.43% | 334B | |
+7.18% | 296B | |
-0.41% | 217B | |
+11.54% | 214B | |
+4.53% | 161B | |
-3.92% | 159B | |
-0.51% | 121B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- ASTRAZENECA : Buy rating from JP Morgan